Cargando…

Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension

Adrenomedullin (ADM) is a novel cardiovascular peptide with anti-inflammatory and antioxidant properties. Chronic inflammation, oxidative stress and calcification play pivotal roles in the pathogenesis of vascular dysfunction in obesity-related hypertension (OH). Our study aimed to explore the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hong-Yu, Wang, Fang-Zheng, Chang, Rui, Wang, Qian, Liu, Si-Yu, Cheng, Ze-Xiong, Gao, Qing, Zhou, Hong, Zhou, Ye-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967515/
https://www.ncbi.nlm.nih.gov/pubmed/36835355
http://dx.doi.org/10.3390/ijms24043943
_version_ 1784897283813277696
author Wang, Hong-Yu
Wang, Fang-Zheng
Chang, Rui
Wang, Qian
Liu, Si-Yu
Cheng, Ze-Xiong
Gao, Qing
Zhou, Hong
Zhou, Ye-Bo
author_facet Wang, Hong-Yu
Wang, Fang-Zheng
Chang, Rui
Wang, Qian
Liu, Si-Yu
Cheng, Ze-Xiong
Gao, Qing
Zhou, Hong
Zhou, Ye-Bo
author_sort Wang, Hong-Yu
collection PubMed
description Adrenomedullin (ADM) is a novel cardiovascular peptide with anti-inflammatory and antioxidant properties. Chronic inflammation, oxidative stress and calcification play pivotal roles in the pathogenesis of vascular dysfunction in obesity-related hypertension (OH). Our study aimed to explore the effects of ADM on the vascular inflammation, oxidative stress and calcification in rats with OH. Eight-week-old Sprague Dawley male rats were fed with either a Control diet or a high fat diet (HFD) for 28 weeks. Next, the OH rats were randomly subdivided into two groups as follows: (1) HFD control group, and (2) HFD with ADM. A 4-week treatment with ADM (7.2 μg/kg/day, ip) not only improved hypertension and vascular remodeling, but also inhibited vascular inflammation, oxidative stress and calcification in aorta of rats with OH. In vitro experiments, ADM (10 nM) in A7r5 cells (rat thoracic aorta smooth muscle cells) attenuated palmitic acid (PA, 200 μM) or angiotensin II (Ang II, 10 nM) alone or their combination treatment-induced inflammation, oxidative stress and calcification, which were effectively inhibited by the ADM receptor antagonist ADM22-52 and AMP-activated protein kinase (AMPK) inhibitor Compound C, respectively. Moreover, ADM treatment significantly inhibited Ang II type 1 receptor (AT1R) protein expression in aorta of rats with OH or in PA-treated A7r5 cells. ADM improved hypertension, vascular remodeling and arterial stiffness, and attenuated inflammation, oxidative stress and calcification in OH state partially via receptor-mediated AMPK pathway. The results also raise the possibility that ADM will be considered for improving hypertension and vascular damage in patients with OH.
format Online
Article
Text
id pubmed-9967515
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99675152023-02-27 Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension Wang, Hong-Yu Wang, Fang-Zheng Chang, Rui Wang, Qian Liu, Si-Yu Cheng, Ze-Xiong Gao, Qing Zhou, Hong Zhou, Ye-Bo Int J Mol Sci Article Adrenomedullin (ADM) is a novel cardiovascular peptide with anti-inflammatory and antioxidant properties. Chronic inflammation, oxidative stress and calcification play pivotal roles in the pathogenesis of vascular dysfunction in obesity-related hypertension (OH). Our study aimed to explore the effects of ADM on the vascular inflammation, oxidative stress and calcification in rats with OH. Eight-week-old Sprague Dawley male rats were fed with either a Control diet or a high fat diet (HFD) for 28 weeks. Next, the OH rats were randomly subdivided into two groups as follows: (1) HFD control group, and (2) HFD with ADM. A 4-week treatment with ADM (7.2 μg/kg/day, ip) not only improved hypertension and vascular remodeling, but also inhibited vascular inflammation, oxidative stress and calcification in aorta of rats with OH. In vitro experiments, ADM (10 nM) in A7r5 cells (rat thoracic aorta smooth muscle cells) attenuated palmitic acid (PA, 200 μM) or angiotensin II (Ang II, 10 nM) alone or their combination treatment-induced inflammation, oxidative stress and calcification, which were effectively inhibited by the ADM receptor antagonist ADM22-52 and AMP-activated protein kinase (AMPK) inhibitor Compound C, respectively. Moreover, ADM treatment significantly inhibited Ang II type 1 receptor (AT1R) protein expression in aorta of rats with OH or in PA-treated A7r5 cells. ADM improved hypertension, vascular remodeling and arterial stiffness, and attenuated inflammation, oxidative stress and calcification in OH state partially via receptor-mediated AMPK pathway. The results also raise the possibility that ADM will be considered for improving hypertension and vascular damage in patients with OH. MDPI 2023-02-15 /pmc/articles/PMC9967515/ /pubmed/36835355 http://dx.doi.org/10.3390/ijms24043943 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Hong-Yu
Wang, Fang-Zheng
Chang, Rui
Wang, Qian
Liu, Si-Yu
Cheng, Ze-Xiong
Gao, Qing
Zhou, Hong
Zhou, Ye-Bo
Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title_full Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title_fullStr Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title_full_unstemmed Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title_short Adrenomedullin Improves Hypertension and Vascular Remodeling partly through the Receptor-Mediated AMPK Pathway in Rats with Obesity-Related Hypertension
title_sort adrenomedullin improves hypertension and vascular remodeling partly through the receptor-mediated ampk pathway in rats with obesity-related hypertension
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967515/
https://www.ncbi.nlm.nih.gov/pubmed/36835355
http://dx.doi.org/10.3390/ijms24043943
work_keys_str_mv AT wanghongyu adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT wangfangzheng adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT changrui adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT wangqian adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT liusiyu adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT chengzexiong adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT gaoqing adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT zhouhong adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension
AT zhouyebo adrenomedullinimproveshypertensionandvascularremodelingpartlythroughthereceptormediatedampkpathwayinratswithobesityrelatedhypertension